How Much Did Ascribe Bioscience Raise?
Funding & Key Investors

Ascribe Bioscience has successfully secured a major strategic investment, marking a significant milestone in its corporate trajectory. With a total capital accumulation of $15M, the firm is well-positioned to accelerate its development of sustainable agricultural solutions. This latest infusion of $15M underscores the growing market confidence in the company's proprietary biopesticide technology and its potential to disrupt traditional chemical-heavy farming practices.

The recent financing round reflects a broader trend of institutional interest in climate-resilient agricultural technologies. By leveraging this capital, Ascribe Bioscience aims to scale its operational capacity and expand its reach within the global enterprise-level agricultural market, solidifying its status as a key player in the bio-innovation landscape.

What is Ascribe Bioscience?

Ascribe Bioscience
Business ServicesResearch & DevelopmentChemicals & Related Products

Founded in 2017 and headquartered in Ithaca, New York, Ascribe Bioscience operates at the intersection of biotechnology and sustainable agriculture. The company specializes in the research and development of environmentally-friendly biopesticides designed to protect crops while minimizing ecological impact. By utilizing advanced molecular signaling pathways, Ascribe provides farmers with high-efficacy alternatives to synthetic pesticides, addressing the urgent global demand for sustainable food production systems.

The company's market position is defined by its commitment to rigorous scientific validation and its ability to integrate seamlessly into existing agricultural workflows. As the industry shifts toward regenerative practices, Ascribe Bioscience serves as a critical partner for large-scale agricultural enterprises seeking to improve yield stability without compromising environmental stewardship.

How much funding has Ascribe Bioscience raised?

Ascribe Bioscience has raised a total of $15M across 1 funding round:

2025

Private Equity

$15M

Private Equity (2025): $15M, investors not publicly disclosed

Key Investors in Ascribe Bioscience

Undisclosed Investor

Undisclosed investor participating in the funding round.

What's next for Ascribe Bioscience?

With the recent influx of capital, Ascribe Bioscience is poised to transition from its current development phase into a period of aggressive commercial scaling. The strategic roadmap likely includes the expansion of its manufacturing capabilities and the acceleration of regulatory approval processes for its core product pipeline. Furthermore, the company is expected to deepen its research initiatives, exploring new applications for its biopesticide platform to address a wider range of crop pathogens.

Looking ahead, the firm will likely focus on establishing strategic partnerships with global agricultural distributors to enhance its market penetration. By maintaining its focus on high-impact, sustainable solutions, Ascribe Bioscience is well-equipped to navigate the complexities of the evolving agricultural sector, ensuring long-term value creation for its stakeholders and contributing to the broader transition toward a more sustainable global food supply chain.

See full Ascribe Bioscience company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Business Services industry

Business ServicesSoftware TestingProject Management
Business ServicesSoftware Testing
Accounting for Legal PracticesBusiness Services
Business ServicesHuman Resources Management Systems (HRMS)

Frequently Asked Questions Regarding Ascribe Bioscience Financial Insights

What are the most recent funding rounds that Ascribe Bioscience has completed, and what were the funding rounds?
Ascribe Bioscience has recently completed 1 funding rounds: Private Equity on Oct 15, 2025.
What is the total amount of funding Ascribe Bioscience has raised to date?
Ascribe Bioscience has raised a total of $15M in funding to date.
How many funding rounds has Ascribe Bioscience completed?
Ascribe Bioscience has completed 1 funding rounds.
How much funding did Ascribe Bioscience raise in its most recent funding round?
Ascribe Bioscience raised $15M in its most recent funding round.
Which was the largest funding round in Ascribe Bioscience's history?
The largest funding round in Ascribe Bioscience's history was $15M.
See more information about Ascribe Bioscience